Cargando…
EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192140/ http://dx.doi.org/10.1016/S1569-1993(21)01000-6 |
| _version_ | 1783705995085611008 |
|---|---|
| author | Brown, C. Archer, M. Carson, L. Collins, N. Daniels, T. Gates, A. Johnstone, Z. Patel, N. Rashid, R. Whitehouse, J.L. |
| author_facet | Brown, C. Archer, M. Carson, L. Collins, N. Daniels, T. Gates, A. Johnstone, Z. Patel, N. Rashid, R. Whitehouse, J.L. |
| author_sort | Brown, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8192140 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81921402021-06-11 EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK Brown, C. Archer, M. Carson, L. Collins, N. Daniels, T. Gates, A. Johnstone, Z. Patel, N. Rashid, R. Whitehouse, J.L. J Cyst Fibros ePoster Sessions European Cystic Fibrosis Society. 2021 2021-06-11 /pmc/articles/PMC8192140/ http://dx.doi.org/10.1016/S1569-1993(21)01000-6 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | ePoster Sessions Brown, C. Archer, M. Carson, L. Collins, N. Daniels, T. Gates, A. Johnstone, Z. Patel, N. Rashid, R. Whitehouse, J.L. EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK |
| title | EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK |
| title_full | EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK |
| title_fullStr | EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK |
| title_full_unstemmed | EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK |
| title_short | EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK |
| title_sort | eps1.02 the impact of covid-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the uk |
| topic | ePoster Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192140/ http://dx.doi.org/10.1016/S1569-1993(21)01000-6 |
| work_keys_str_mv | AT brownc eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT archerm eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT carsonl eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT collinsn eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT danielst eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT gatesa eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT johnstonez eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT pateln eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT rashidr eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT whitehousejl eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk AT eps102theimpactofcovid19ontheprescribingpracticeofspecialistcysticfibrosisphysiotherapistnonmedicalprescribersintheuk |